MENU
+Compare
PILL
ETF ticker: NYSE ARCA
AS OF
Nov 13, 04:59 PM (EDT)
Price
$9.02
Change
-$0.40 (-4.25%)
Net Assets
12.75M

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
PILL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PILL with price predictions
Nov 12, 2025

PILL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PILL turned positive on November 11, 2025. Looking at past instances where PILL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2025. You may want to consider a long position or call options on PILL as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where PILL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PILL broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF is 43.09B. The market cap for tickers in the group ranges from 469.24M to 910.93B. LLY holds the highest valuation in this group at 910.93B. The lowest valued company is OMER at 469.24M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was 21%. For the same ETF, the average monthly price growth was 53%, and the average quarterly price growth was 268%. COLL experienced the highest price growth at 32%, while XERS experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was -11%. For the same stocks of the ETF, the average monthly volume growth was 63% and the average quarterly volume growth was 61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 67
Price Growth Rating: 46
SMR Rating: 75
Profit Risk Rating: 75
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
PILL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/